News Center

EssilorLuxottica revenue rises 7.3% in H1, says AI glasses ’speeding up’

EssilorLuxottica revenue rises 7.3% in H1, says AI glasses ’speeding up’

Investing.com -- EssilorLuxottica posted a 7.3% year-on-year increase in revenue for the first half of 2025 at constant exchange rates, driven by strong growth in its Direct to Consumer segment and surging sales of its AI-enabled smart glasses. Group revenue reached €14.02 billion in H1, with adjusted operating profit steady at 18.3% of sales despite pressure from new U.S. import duties. Op ...

2025-07-29 03:10:47
Carlyle picks three veterans for newly minted role of co-president

Carlyle picks three veterans for newly minted role of co-president

By Arasu Kannagi Basil (Reuters) -Investment firm Carlyle announced on Monday it has rejigged its senior leadership ranks and named three of its veterans for its newly created role of co-president. Chief Financial Officer John Redett, credit head Mark Jenkins and client business head Jeff Nedelman will become Carlyle’s co-presidents, effective January 1, 2026. "These individuals, all Carlyle ve ...

2025-07-29 03:08:17
Wise shareholders approve plan to shift primary listing to U.S.

Wise shareholders approve plan to shift primary listing to U.S.

Investing.com -- Shareholders of British fintech Wise (LON:WISEa) Plc on Monday approved plans to shift the company’s primary stock market listing to the United States. The decision was made during an extraordinary general meeting where shareholders voted in favor of the proposed change in primary listing location. This article was generated with the support of AI and reviewed by an editor. Fo ...

2025-07-29 03:05:41
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say

EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say

By Bhanvi Satija (Reuters) -The European Union’s trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday.  The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of the tariffs, one of the analysts s ...

2025-07-29 03:02:09